News
MiSight®1 day's dual focus design slows myopia progression
MiSight®1 day's dual focus design slows myopia progression
Concentric ring design inspired by New Zealand research proves effective.
Growing myopia awareness drives MYC clinic expansion
High costs and insurance gaps challenge underserved area expansion.
Singapore faces resource challenges in myopia management
Rising myopia cases increase pressure on healthcare system resources.
New MRI technique visualises complete eye structure
3D MRI offers objective diagnosis for eye deformities and pathologic myopia.
CSMC receives PhilHealth accreditation for Z-benefit breast cancer package
The benefit allows eligible individuals to access up to $23.8k (Php1.4m) in coverage.
What factors fuel the global infusion pump market?
Key drivers include chronic conditions and an ageing population.
Global spine surgery products market projected to hit $20b by 2031
Its expansion is attributed to developments in healthcare infrastructure.
Turkey’s medical tourism market to reach $3.48b by 2029
Inbound medical tourism currently dominates the outbound segment.
Australian gov’t allocates $271.2k to Tamworth Hospital upgrades
This is part of a $7.8m (A$12m) investment under the Regional Health Minor Works Programme.
Australia launches menopause hub at the Royal Hospital for Women, Randwick
The hub includes NSW’s first publicly funded hormone and mood clinic.
Here’s what’s driving India’s medical device sector growth
Developments in tier II and III cities include partnerships and healthcare infrastructure expansion.
South Korea’s pharmaceutical sales to hit $40.6b by 2028
It is expected to rise at a compound annual growth rate of 10% in US dollar terms.
SG’s Sengkang General Hospital unveils photon counting CT for public sector
The tech reduces radiation and contrast doses whilst maintaining image quality.
Vietnam’s DND International Eye Hospital adopts SMILE Pro technology
The tech features a 2mm incision that allows for rapid correction of refractive errors.
7MM Parkinson’s disease pipeline focuses on disease-modifying agents
There are a total of 93 products in Phase I-III development for PD treatment.